Dr. Moore is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1275 York Avenue
New York, NY 10065
Education & Training
Memorial Sloan Kettering Cancer CenterResidency, Radiation Oncology, 2023
University of Texas Southwestern Medical SchoolClass of 2018
Certifications & Licensure
NJ State Medical License 2023 - 2025
NY State Medical License 2021 - 2024
Publications & Presentations
PubMed
- 48 citationsTumor-selective use of DNA base excision repair inhibition in pancreatic cancer using the NQO1 bioactivatable drug, β-lapachoneGaurab Chakrabarti, Molly A. Silvers, Mariya Ilcheva, Yuliang Liu, Zachary R. Moore
Scientific Reports. 2015-11-25 - 17 citationsNanotechnology-enabled delivery of NQO1 bioactivatable drugs.Xinpeng Ma, Zachary R. Moore, Gang Huang, Xiumei Huang, David A. Boothman
Journal of Drug Targeting. 2015-10-09 - 98 citationsTargeting glutamine metabolism sensitizes pancreatic cancer to PARP-driven metabolic catastrophe induced by ß-lapachone.Gaurab Chakrabarti, Zachary R. Moore, Xiuquan Luo, Mariya Ilcheva, Aktar Ali
Cancer & Metabolism. 2015-10-12
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
